World TB Day 2012 Global Events

U.S. Congress World TB Day Congressional Briefing

Tuberculosis - Why This Ancient Disease Remains a Global Health Threat

In cooperation with the House TB Elimination Caucus, co-chaired by Reps. Engel (D-NY), Green (D-TX) & Young (R-AK)

Tuesday, March 20, 2012
12:00pm - 1:30pm
Room B-340, Rayburn House Office Building

Lunch will be served

You are invited to attend an educational briefing on tuberculosis - what it is, how it spreads and why we have not eliminated this ancient disease that persists in the U.S. and is the second leading infectious disease worldwide, killing 1.4 million people annually. All U.S. states continue to report cases of TB. Border states and those with large Native American and other racial and ethnic minority populations face special challenges. Special areas of focus of the briefing will include drug resistant TB and TB in children. Worldwide, major gains have been made in expanding access to treatment but there are still challenges ahead including ensuring prevention and care of multidrug-resistant tuberculosis. Join us to learn why U.S. leadership on this global health threat is critical.


Mario Raviglione, M.D., Director, Stop TB Department, World Health Organization, Moderator

RADM Kenneth G. Castro, M.D., Director, Division of TB Elimination, Centers for Disease Control and Prevention

Jeffrey Starke, M.D., Professor of Pediatrics, Baylor College of Medicine and Director, Children's TB Clinic, Texas Children's Hospital

Rachel Orduno, MSW, Vice-President, TB Photovoice & Advocate for Persons Affected by TB

Please RSVP to Chris Hughes of the American Thoracic Society at or at (202) 296.9770

Commemorate World TB Day 2012 with PATH

March 20, 2012
8:30 a.m.-11:30 a.m.
PATH, 455 Massachusetts Avenue, Suite 1000
Washington, DC 20001

The TB problem is not too big to solve! From scientists to advocates to communities, committed people around the world are fighting against this devastating disease. Please join us as some of these everyday heroes share experiences and stories about the challenges they face and solutions to move us forward.

The event is open to the general public and will feature guest speakers from several African countries, the Executive Secretary of the Stop TB Partnership and the District of Columbia Department of Public Health. There will be interactive activity sessions and more. You will also learn how you can take action to create a world free from TB.

Breakfast and a light lunch will be provided.

RSVP: Please RSVP to Holly Greb at by March 9, 2012.

World TB Day event at the Muséum de Toulouse Auditorium

Picot de Lapeyrouse
35 allées Jules Guesde
1 5 H E U R E S

Dans le cadre de la journée mondiale de lutte contre la tuberculose et à l’initiative de l'Institut de Pharmacologie et de Biologie Structurale (CNRSUniversité de Toulouse), le Muséum de Toulouse accueille une rencontredébat regroupant des conférences d’intervenants du CNRS, de l’OMS, de TB-VI et d'UNITAID.

Toulouse occupe une position stratégique dans la lutte contre la tuberculose. Plusieurs laboratoires sont impliqués dans la recherche tant sur la maladie elle même que sur les moyens de son contrôle.

Les acteurs issus des différentes structures présenteront au public, à l’occasion de cette rencontre, l’épidémiologie de la maladie, les grands enjeux de santé publique et la recherche telle qu’elle est menée dans nos laboratoires. Par ailleurs, les enjeux économiques et la question du financement de la recherche de nouveaux vaccins seront discutés.

Ouverture par Dr. Philippe Douste-Blazy, Ancien Ministre
Secrétaire Général Adjoint des Nations Unies,
Président du Conseil d'Administration d'UNITAID
Dr. Ulrich Fruth, Organisation Mondiale de la Santé
"Eliminer la tuberculose, est-ce possible ?"
Dr. Joris Vandeputte, Tuberculosis Vaccine Initiative
"La tuberculose: tous concernés !"
Dr. Olivier Neyrolles, Institut de Pharmacologie et de Biologie Structurale,
CNRS-Université de Toulouse
"Des sanatoriums à la post-génomique : nouveaux regards sur la tuberculose"


Local and global

The UCL Institute for Global Health is marking World TB Day with a meeting that addresses tuberculosis as a challenge to London and UK health services and sets it in a global context, with the launch of Tuberculosis and TB/HIV; Controversies and unanswered questions, a Journal of Infectious Diseases special supplement edited by Professor Ali Zumla (UCL Centre for Clinical Microbiology) and Marco Schito (National Institutes of Health, USA).

The introductory session includes presentations from NHS London and UCL researchers, and will focus on local initiatives to combat tuberculosis. Most of the day will be devoted to presentations by the lead authors from the JID supplement, which addresses the key issues in TB control today with presentations on drug development, clinical trials, diagnosis and biomarkers, epidemiology immunology and paediatric tuberculosis.

The meeting will be of interest to scientists, clinicians and students. The conference is free to attend but registration is required.

Friday 23 March 2012, 8.30am - 6.30pm

  • Christian Leinhardt (WHO)
  • Haileyesus Getahun Gebre (WHO)
  • Payam Nahid (NIH)
  • Markus Maeurer (Karolinska Institute)
  • Michael Hoelscher (Munich Univ)
  • Luis Cuevas (LSTM) and others

Symposium: Europe and ACP together against tuberculosis

On the occasion of World Tuberculosis Day

22 March 2012, 11.00-15.00h, including lunch

European Parliament, Rue Wiertz 60, Brussels

Room Paul-Henri Spaak P5B001, interpretation EN/FR

Host: Mr Charles Goerens, MEP

Co-hosts : MEP’s Ms Maria da Graça Carvalho and Ms Linda McAvan


11.00: Introduction by Mr Charles Goerens, MEP

11.10: H.E. Louis Michel, MEP and co-chair of Joint Parliamentary Assembly of the European Parliament and Parliaments of ACP Countries (JPA): Innovation to strengthen ACP / EU collaboration

11.30: H.E. Ms Hon Beth Mugo, Minister of Public Health and Sanitation of Kenya: Tuberculosis in a high burden country, Kenya (to be confirmed)

11.50: H.E. Dr Mohamed Ibn Chambas, Secretary General of the ACP: Health in ACP countries as driver for poverty reduction with reference on TB

12.10: Lunch

13.00: H.E. Dr. Zsuzsanna Jakab, Director of WHO Europe: Tuberculosis, a challenge for Europe

13.20: H.E. Ms Naledi Pandor, Minister of Science and Technology of South Africa: North South and South North collaborations to develop new vaccines for tuberculosis: the experience of South Africa

13.40: Prof. Dr Charles Mgone, Executive Director of the European and Developing Countries Clinical Trials Partnership (EDCTP): How EDCTP strengthened North/South and South/North collaborations in tuberculosis clinical trials.

14.00: Dr. Jelle Thole, Director TBVI: Blueprint for New TB Vaccines

14.20: Dr. Lucica Ditiu, Executive Director Stop TB Partnership:Tuberculosis - new tools, new models of delivery, new type of financing

14.40: Discussion and conclusions by Mr Charles Goerens.

If you would like to join this symposium, please complete the registration form before 12 March on